UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Hibernia Wealth Partners LLC

Hibernia Wealth Partners LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1,102.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 577 shares of the healthcare conglomerate’s stock after purchasing an additional 529 shares during the quarter. Hibernia Wealth Partners LLC’s holdings in UnitedHealth Group were worth $304,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in UNH. State Street Corp increased its stake in UnitedHealth Group by 1.7% during the second quarter. State Street Corp now owns 46,313,751 shares of the healthcare conglomerate’s stock worth $22,260,241,000 after acquiring an additional 764,872 shares during the last quarter. Wellington Management Group LLP increased its stake in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Morgan Stanley increased its stake in UnitedHealth Group by 13.8% during the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC increased its stake in UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its position in shares of UnitedHealth Group by 3.5% in the second quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock worth $5,647,433,000 after buying an additional 399,739 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on UNH. Stephens reaffirmed an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Bank of America reissued a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Piper Sandler reduced their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Finally, Barclays initiated coverage on UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target for the company. One analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $579.33.

UnitedHealth Group Stock Performance

UNH traded up $1.60 during trading hours on Friday, hitting $494.70. The company’s stock had a trading volume of 3,820,008 shares, compared to its average volume of 4,274,309. The company has a 50-day simple moving average of $502.66 and a 200 day simple moving average of $518.44. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $456.08 billion, a PE ratio of 20.75, a PEG ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s quarterly revenue was up 14.1% on a year-over-year basis. During the same period last year, the company posted $5.34 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.